Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Bradykinin antagonists from Pfizer

Oct. 23, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Toxicity studies reported for new expectorant from SS Pharm.

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

Oct. 16, 1997

New bronchodilators from Nippon Suisan

Oct. 16, 1997

FDA actively reviewing TOBI

Oct. 13, 1997

Mutual Recognition Procedure concludes for Nasonex

Oct. 13, 1997

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....